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Abstract—Computer-aided diagnosis has become a necessity
for accurate and immediate coronavirus disease 2019 (COVID-
19) detection to aid treatment and prevent the spread of the
virus. Compared to other diagnosis methodologies, chest X-ray
(CXR) imaging is an advantageous tool since it is fast, low-cost,
and easily accessible. Thus, CXR has a great potential not only
to help diagnose COVID-19 but also to track the progression
of the disease. Numerous studies have proposed to use Deep
Learning techniques for COVID-19 diagnosis. However, they have
used very limited CXR image repositories for evaluation with a
small number, a few hundreds, of COVID-19 samples. Moreover,
these methods can neither localize nor grade the severity of
COVID-19 infection. For this purpose, recent studies proposed
to explore the activation maps of deep networks. However, they
remain inaccurate for localizing the actual infestation making
them unreliable for clinical use. This study proposes a novel
method for the joint localization, severity grading, and detection
of COVID-19 from CXR images by generating the so-called
infection maps that can accurately localize and grade the severity
of COVID-19 infection. To accomplish this, we have compiled the
largest COVID-19 dataset up to date with 2951 COVID-19 CXR
images, where the annotation of the ground-truth segmentation
masks is performed on CXRs by a novel collaborative expert
human-machine approach. Furthermore, we publicly release the
first CXR dataset with the ground-truth segmentation masks of
the COVID-19 infected regions. A detailed set of experiments
show that state-of-the-art segmentation networks can learn to
localize COVID-19 infection with an F1-score of 85.81%, that
is significantly superior to the activation maps created by the
previous methods. Finally, the proposed approach achieved a
COVID-19 detection performance with 98.37% sensitivity and
99.16% specificity.
Index Terms—SARS-CoV-2, COVID-19 Detection, COVID-19
Infection Segmentation, Deep Learning
I. INTRODUCTION
CORONAVIRUS disease 2019 (COVID-19) caused bysevere acute respiratory syndrome Coronavirus-2 (SARs-
CoV-2) was first reported in December 2019 in Wuhan, China.
The highly infectious disease rapidly spread around the World
with millions of positive cases. As a result, COVID-19 was
declared as a pandemic by the World Health Organization in
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Fig. 1: The COVID-19 sample CXR images, their correspond-
ing ground-truth segmentation masks which are annotated by
the collaborative human-machine approach, and the generated
infection maps from the state-of-the-art segmentation models.
March 2020. The disease may lead to hospitalization, intuba-
tion, intensive care, and even death, especially for the elderly
[1], [2]. Naturally, reliable detection of the disease has the
utmost importance. However, the diagnosis of COVID-19 is
not straight-forward since its symptoms, such as cough, fever,
breathlessness, and diarrhea are generally indistinguishable
within other viral infections [3], [4].
The diagnostic tools to detect COVID-19 are currently
reverse transcription of polymerase chain reaction (RT-PCR)
assays and chest imaging techniques, such as Computed To-
mography (CT) and X-ray imaging. Primarily, RT-PCR has
become the gold standard in the diagnosis of COVID-19
[5], [6]. However, RT-PCR arrays have a high false alarm
rate which may be caused by the virus mutations in the
SARS-CoV-2 genome, sample contamination, or damage to
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2the sample acquired from the patient [7], [8]. In fact, it
is shown in hospitalized patients that RT-PCR sensitivity is
low and the test results are highly unstable [6], [9]–[11].
Therefore, it is recommended to perform chest CT imaging
initially on the suspected COVID-19 cases [12], since it is
a more reliable clinical tool in the diagnosis with higher
sensitivity compared to RT-PCR. Hence, several studies [12]–
[14] suggest performing CT on the negative RT-PCR findings
of the suspected cases. However, there are several limitations
of CT scans. Their sensitivity is limited in the early COVID-
19 phase groups [15], and they are limited to recognize only
specific viruses [16], slow in image acquisition, and costly.
On the other hand, X-ray imaging is faster, cheaper, and less
harmful to the body in terms of radiation exposure compared
to CT [17], [18]. Moreover, unlike CT devices, X-ray devices
are easily accessible; hence, reducing the risk of COVID-
19 contamination during the imaging process [19]. Currently,
chest X-ray (CXR) imaging is widely used as an assistive tool
in COVID-19 prognosis, and it is reported to have a potential
diagnosis capability in recent studies [20].
In order to automate COVID-19 detection/recognition from
CXR images, many studies [17], [21]–[27] have proposed to
use deep Convolutional Neural Networks (CNNs). However,
the main limitation of these studies is that the data is scarce
for the target COVID-19 class. Such limited amount of data
degrades the learning performance of the deep networks. Two
recent studies [28] and [29] have addressed this drawback with
a compact network structure and achieved the state-of-the-
art detection performance over the benchmark QaTa-COV19
and Early-QaTa-COV19 datasets that consist of 462 and 175
COVID-19 CXR images, respectively. Despite the fact that
these datasets were the largest available at that time, such a
limited number of COVID-19 samples raises robustness and
reliability issues for the proposed methods in general.
Moreover, all these previous machine learning solutions
with X-ray imaging remain limited to only COVID-19 detec-
tion. However, as stated by Shi [30], COVID-19 pneumonia
screening is important for evaluating the status of the patient
and treatment. Therefore, along with the detection, COVID-
19 related infection localization is another crucial problem.
Hence, several studies [31]–[33] produced activation maps
that are generated from different Deep Learning (DL) models
trained for COVID-19 detection (classification) task to localize
COVID-19 infection in the lungs. Infection localization has
two vital objectives: an accurate assessment of the infection
location and the severity of the disease. However, results
of previous studies show that the activation maps generated
inherently from the underlying DL network may fail to accom-
plish both objectives, that is, irrelevant locations with biased
severity grading appeared in many cases. To overcome these
problems, two studies [34], [35] proposed to perform lung
segmentation as a first step in their approaches. This way,
they have narrowed the region of interest down to the regions
of lungs to increase reliability of their methods. Overall, until
this study, screening COVID-19 infection from such activation
maps produced by classification networks was the only option
for the localization due to the absence of ground-truth of
the datasets available in the literature. Many studies [30],
[34], [36]–[38] have COVID-19 infection ground-truths for CT
images; however, ground-truth segmentation masks for CXR
images are non-existent.
In this study, in order to overcome the aforementioned
limitations and drawbacks, first, the benchmark dataset QaTa-
COVSeg proposed by the researchers of Qatar University and
Tampere University in [28] and [29] is extended to include
2951 COVID-19 samples. This new dataset is 3-20 times larger
than those used in earlier studies. The extended benchmark
dataset, QaTa-COVSeg with around 15, 500 CXR images, is
not only the largest ever composed dataset, but it is the
first dataset that has the ground-truth segmentation masks for
COVID-19 infection regions, some samples are shown in Fig.
1. To obtain the ground-truth, an expert human-machine col-
laborative approach is introduced to improve the segmentation
masks manually drawn by medical doctors (MDs). This is
an iterative process, where MDs initiate the segmentation by
”manually-drawn” segmentation masks for a subset of CXR
images. Then, the trained segmentation networks over this
subset generate their own ”competing” masks and the MDs are
asked to compare them pair-wise (initial manual segmentation
versus automatically segmented mask) for the same patient.
The networks also segment the remaining CXR images, which
are verified by the expert MDs. Such a verification improves
the quality of the generated masks as well as the training.
The human-machine collaboration continues until the MDs
are fully satisfied, i.e., a satisfactory mask can be found
among the masks generated by the networks for all CXR
images in the dataset. In this study, we show that even with
two stages (iterations), highly superior infection maps can be
obtained, and an elegant COVID-19 detection performance can
be achieved.
For the infection map generation, we use the following state-
of-the-art deep networks: U-Net [39], U-Net++ [40], which
provide top performances in biomedical image segmentation,
and Deep Layer Aggression (DLA) [41] encoder-decoder
CNN (E-D CNN) type segmentation networks. Moreover, the
encoder structure of the E-D CNN architectures is varied:
CheXNet [42] (fined-tuned version of DenseNet-121 [43]),
DenseNet-121, Inception-v3 [44], and ResNet-50 [45]. Next,
the infection maps are generated from the predictions of the
E-D CNN models to visualize/detect COVID-19 infection.
The rest of the paper is organized as follows. In section
II-A, we introduce the benchmark QaTa-COVSeg dataset. Our
novel human-machine collaborative approach for the ground-
truth annotation is explained in Section II-B. Next, the details
of COVID-19 infected region segmentation, and the infection
map generation and COVID-19 detection are presented in
Sections II-C and II-D, respectively. The experimental setup
and results with the benchmark dataset are reported in Section
III-A and III-B, respectively. Finally, we conclude the paper
in Section IV.
II. MATERIALS AND METHODOLOGY
The proposed approach in this study is composed of three
main phases: 1) training the state-of-the-art deep models for
COVID-19 infected region segmentation using the ground-
truth segmentation masks, 2) infection map generation from
3Fig. 2: The pipeline of the proposed approach has three stages: COVID-19 infected region segmentation, infection map
generation, and COVID-19 detection. The CXR image is the input to the trained E-D CNN and the network’s probabilistic
prediction is used to generate infection maps. The generated infection maps are used for COVID-19 detection.
the trained segmentation networks, and 3) COVID-19 detec-
tion as it can be depicted in Fig. 2. In this section, we first
detail the creation of the benchmark QaTa-COVSeg dataset.
Then, the proposed approach for collaborative human-machine
ground-truth generation is introduced.
A. The Benchmark QaTa-COVSeg Dataset
The researchers of Qatar University and Tampere University
have compiled the largest COVID-19 dataset up to date: QaTa-
COVSeg including 2951 COVID-19, and 12, 544 normal (con-
trol group) CXR images. To create QaTa-COVSeg, we have
utilized several publicly available, scattered, and different for-
mat datasets and repositories. Therefore, the collected images
from the datasets had some duplicate, over-exposed and low-
quality images that were identified and removed in the pre-
processing stage. Consequently, the COVID-19 CXRs are from
different publicly available sources resulting in high intra-
class dissimilarity as depicted in Fig. 3. The image sources
of normal and COVID-19 CXRs are detailed as follows:
Fig. 3: The COVID-19 CXR samples from the benchmark
QaTa-COVSeg dataset.
Normal CXRs: RSNA pneumonia detection challenge
dataset [46] is comprised of about 29.7K CXR images, where
8851 images are normal. All CXRs in the dataset are in
DICOM format, a popularly used format for medical imaging.
Padchest dataset [47] consists of 160, 868 CXR images from
67, 625 patients, where 37, 871 images are from normal class.
The images are evaluated and reported by radiologists at
Hospital Sun Juan in Spain during 2009 − 2017. The dataset
includes six different position views of CXR and additional
information regarding image acquisition and patient demogra-
phy. Paul Mooney [48] has released an X-ray dataset of 5863
CXR images from a total of 5856 patients, where 1583 images
are from normal class. The data is collected from pediatric
patients aging one to five years old at Guangzhou Women and
Children’s Medical Center, Guangzhou. The dataset in [49]
consists of 7470 CXR images and the corresponding radiolo-
gist reports from the Indiana Network for Patient Care, where
a total of 1343 frontal CXR samples are labeled as normal. In
[50], there are 80 normal CXRs from the tuberculosis control
program of the Department of Health and Human Services of
Montgomery County and 326 normal CXRs from Shenzhen
Hospital. In this study, a total of 12, 544 normal CXRs are
gathered from the aforementioned datasets.
COVID-19 CXRs: BIMCV-COVID19+ [51] is the largest
publicly available dataset with 2473 COVID-19 positive CXR
images. The CXR images of BIMCV-COVID19+ dataset were
recorded with computed radiography (CR) and digital X-ray
(DX) machines. Hannover Medical School and Institute for
Diagnostic and Interventional Radiology [52] released 183
CXR images of COVID-19 patients. A total of 959 CXR
images are from public repositories: Italian Society of Medical
and Interventional Radiology (SIRM), GitHub, and Kaggle
[35], [53]–[56]. As mentioned earlier, any duplication and low-
quality images are removed since COVID-19 CXR images are
collected from different public datasets and repositories. In this
study, a total of 2951 COVID-19 CXRs are gathered from the
aforementioned datasets. Therefore, COVID-19 CXRs are of
different age, group, gender, and ethnicity.
4Fig. 4: The two stages of the human-machine collaborative approach. Stage I: A subset of CXR images with manually drawn
segmentation masks are used to train three different deep networks in a 5-fold cross-validation scheme. The manually drawn
ground-truth (a), and the three predictions (b, c, d) are blindly shown to MDs, and they select the best ground-truth mask. Stage
II: Five deep networks are trained over the best segmentation masks selected. Then, they are used to produce the segmentation
masks for the rest of the CXR dataset (a, b, c, d, e), which are shown to MDs.
B. Collaborative Human-Machine Ground-Truth Annotation
Recent developments in machine and deep learning tech-
niques led to state-of-the-art performance in many computer
vision (CV) tasks, such as image classification, object de-
tection, and image segmentation. However, supervised DL
methods require a huge amount of annotated data. Otherwise,
the limited amount of data degrades the performance of the
deep network structures since their generalization capability
depends on the availability of large datasets. Nevertheless,
to produce ground-truth segmentation masks, pixel-accurate
image segmentation by human experts can be a cumbersome
and highly subjective task even for moderate size datasets.
In order to overcome this challenge, in this study, we
propose a novel collaborative human-machine approach to
accurately produce the ground-truth segmentation masks for
infected regions directly from the CXR images. The proposed
approach is performed in two main stages. First, a group of
expert MDs manually segment the infected regions of a subset
of (500 in our case) CXR images. Then, several segmentation
networks that are inspired by the U-Net [39] structure with
a 5-fold cross-validation scheme, are trained over the initial
ground-truth masks. For each fold, the segmentation masks of
the test samples are predicted by the networks. The network
predicted masks along with the initial (MD drawn) ground-
truth masks, and original CXR image are assessed by the MDs,
and the best segmentation mask among them is selected. Steps
of Stage-I are illustrated in Fig. 4 (top). At the end of the
first stage, collaboratively annotated ground-truth masks for
the subset of CXR images are formed, and they are obviously
superior to the initial manually drawn masks since they are
selected by the MDs. An interesting observation in this stage
was that MDs preferred the machine-generated masks over the
manually drawn masks in the first stage in three out of five
cases.
In the second stage five deep networks, inspired by U-Net
[39], UNet++ [40], and DLA [41] architectures are trained
over the collaborative masks, which were formed in Stage-
I. The trained segmentation networks are used to predict the
segmentation masks of the rest of the data, which is around
2400 unannotated COVID-19 images. Among the five predic-
tions, the expert MDs select the best one as the ground-truth
or deny all if none was found successful. For the latter case,
MDs were asked to draw the ground-truth masks manually.
However, we notice that this was indeed a minority case that
included less than 5% of unannotated data. The steps of Stage-
II are shown in Fig. 4 (bottom). As a result, the ground-
truth masks for 2951 COVID-19 CXR images are gathered to
construct the benchmark QaTa-COVSeg dataset. The proposed
approach does not only save valuable human labor time, but
it also improves the quality and reliability of the masks by
reducing the subjectivity with Stage-II verification step.
C. COVID-19 Infected Region Segmentation
Segmentation of COVID-19 infection is the first step of our
proposed approach as depicted in Fig. 2. Once the ground-truth
annotation for QaTa-COVSeg benchmark dataset is formed
as explained in the previous section, we perform infected
region segmentation extensively with 24 different network
5configurations. We have used three different segmentation
models: U-Net, UNet++ and DLA, with four different encoder
structures: CheXNet, DenseNet-121, Inception-v3 and ResNet-
50, and frozen & not frozen encoder weight configurations.
1) Segmentation Models: We have tried distinct segmenta-
tion model structures starting from shallow to deep structures
with varied configurations as follows:
• U-Net [39] is an outperforming network for medical
image segmentation applications with a u-shaped archi-
tecture as the encoder part is symmetric with respect to
its decoder part. Therefore, this unique decoder structure
with many feature channels allows the network to carry
the information through its latest layers.
• UNet++ [40] has further developed the decoder structure
of U-Net by connecting the encoder to the decoder with
the nested dense convolutional blocks. This way, the
bridge between the encoder and decoder parts are more
firmly knit; thus, the information can be transferred to
its final layers more intensively compared to the classic
U-Net.
• DLA [41] investigates the connecting bridges between
the encoder and decoder, and proposes a way to fuse
the semantic and spatial information with dense layers,
which are progressively aggregated by iterative merging
to deeper and larger scales.
2) Encoder Selections for Segmentation Models: In this
study, we use several deep CNNs to form the encoder part
of the above-mentioned segmentation models as follows:
• DenseNet-121 [43] is a deep network with 121 layers,
each with additional input nodes connecting all the layers
directly with each other. Therefore, the maximum infor-
mation flow through the network is satisfied.
• CheXNet [42] is based on the architecture of DenseNet-
121, which is trained over the 14-class ChestX-ray14
dataset [57] to detect pneumonia cases from CXR images.
In [42], DenseNet-121 is initialized with the ImageNet
weights, and fine-tuned over 100K CXR images resulting
the state-of-the-art results on the ChestX-ray14 dataset
with a better performance compared to the conclusions
of radiologists.
• Inception-v3 [44] achieves state-of-the-art results with
much less computational complexity compared to its
deep competitors by factorizing the convolutions and
pruning the dimensions inside the network. Despite the
less complexity, it preserves a higher performance.
• ResNet-50 [45] introduces a deep residual learning
framework that forces the desired mapping of the input
to a residual mapping. It is possible to achieve this goal
by the shortcut connections on the stacked layers. These
connections enable to merge the input and output of
the stacked layers by addition operations; therefore, the
problem of gradient vanishing is prevented.
We perform transfer learning on the encoder side of the seg-
mentation models by initializing the layers with the ImageNet
weights, except for CheXNet which is pre-trained on the
ChestX-ray14 dataset. We tried two configurations, in the first
we freeze the encoder layers, while in the second, they are
allowed to vary.
3) Hybrid Loss Function: In this study, we have performed
training the segmentation networks with a hybrid loss function
by combining focal loss [58] together with dice loss [59] to
achieve a better segmentation performance. We use focal loss
since COVID-19 infected region segmentation is an imbal-
anced problem: the number of background pixels is superior
to the foreground’s. Let the ground-truth segmentation mask
be Y, where each pixel class label is defined as y, and the
network prediction as yˆ. We define the pixel class probabilities
as for the positive class P (y = 1) = p, and for the negative
class P (y = 0) = 1 − p. On the other hand, the network
prediction probabilities are modeled by the logistic function
using the sigmoid curve as,
P (yˆ = 1) =
1
1 + e−z
= q (1)
P (yˆ = 0) = 1− 1
1 + e−z
= 1− q (2)
where z is some function of the input CXR image X. Then,
we define the cross-entropy (CE) loss as follows:
CE(p, q) = −p log q − (1− p) log(1− q). (3)
A common solution to address the class imbalance problem
is to add a weighting factor α ∈ [0, 1] for the positive class,
and 1 − α for the negative class, which defines the balanced
cross-entropy (BCE) loss as,
BCE(p, q) = −αp log q − (1− α)(1− p) log(1− q). (4)
In this way, the importance of positive and negative samples
are balanced. However, adding the α factor does not solve the
issue for the large class imbalance scenario. This is because the
network cannot distinguish outliers (hard samples) and inliers
(easy samples) with the BCE loss. To overcome this drawback,
focal loss [58] proposes to set focusing parameter γ ≥ 0 in
order to down-weight the loss of easy samples that occur with
small errors; so that the model can be forced to learn hard
negative samples. The focal (F) loss is defined as,
F (p, q) = −α(1−q)γp log q−(1−α)qγ(1−p) log(1−q). (5)
where F loss is equivalent to BCE loss when γ = 0. In our
experimental setup, we use the default setting as α = 0.25, and
γ = 2 for all the networks. To achieve a good segmentation
performance, we combined focal loss with dice loss, which is
based on the dice coefficient (DC) defined as follows:
DC =
2|Y ∩ Yˆ|
|Y| ∪ |Yˆ| (6)
where Yˆ is the predicted segmentation mask of the network.
Hence, the DC can be interpreted as a dice (D) loss as follows:
D(p, q) = 1− 2
∑
ph,wqh,w∑
ph,w +
∑
qh,w
(7)
where h and w are height and width of the ground-truth and
prediction masks Y and Yˆ, respectively. Finally, we combined
D and F losses by summation to achieve the so-called hybrid
loss function for the segmentation networks.
6Fig. 5: The three COVID-19 CXR test samples, X with
the corresponding ground-truth masks, Y. The color-coded
network predictions, YˆR,G,B are reflected translucent onto
the X to generate infection map on the lungs, where Yˆ > 0.
D. Infection Map Generation and COVID-19 Detection
Having the training set of COVID-19 CXR images via the
collaborative human-machine approach explained in Section
II-A, we train the aforementioned segmentation networks to
produce infection maps. We train the networks with a 5-fold
cross-validation scheme, where in each fold we feed each test
CXR sample X into the network. Then, we obtain the network
prediction mask Yˆ, which is used to generate an infection
map that is a measure of infected region probabilities on
the input X. Each pixel in Yˆ is defined as Yˆh,w ∈ [0, 1],
where h and w represent the size of the image. We then
apply an RGB-based color transform, i.e., the jet color scale
to obtain the RGB version of the prediction mask, YˆR,G,B
as shown in Fig. 5 for a pseudo-colored probability measure
visualization. The infection map is generated as a reflection
of the network prediction YˆR,G,B onto the CXR image X.
Hence, for visualization, we form the imposed image by
concatenating the hue and saturation components of YˆH,S,V,
and value component of XH,S,V. Finally, the imposed image
is converted back to RGB domain. In the infection map, we
do not show the pixels/regions with zero probabilities for
a better visualization effect. This way, the infected regions,
where Yˆ > 0 are shown translucent as in Fig 5.
Along with the infection map generation, which already
provides localization and segmentation of COVID-19 infec-
tion, COVID-19 detection can easily be performed using the
proposed approach. The detection of COVID-19 is performed
based on the predictions of the trained segmentation networks.
Accordingly, a test sample is classified as COVID-19 class if
Yˆ ≥ 0.5 at any pixel location.
III. EXPERIMENTAL RESULTS
In this section, first, the experimental setup is presented.
Then, both numerical and visual results are reported with an
extensive set of comparative evaluations over the benchmark
QaTa-COVSeg dataset. Finally, visual comparative evaluations
are presented between the infection maps and the activation
maps extracted from state-of-the-art deep models.
A. Experimental Setup
Quantitative evaluations for the proposed approach are per-
formed for both COVID-19 infected region segmentation and
COVID-19 detection. COVID-19 infected region segmentation
is evaluated on a pixel-level, where we consider the foreground
(infected region) as the positive class, and background as the
negative class. For COVID-19 detection, the performance is
computed per CXR sample, and we consider COVID-19 as the
positive class and the control group (normal) as the negative
class. Overall, elements of the confusion matrix are formed as
follows: true positive (TP): the number of correctly detected
positive class members, true negative (TN): the number of
correctly detected negative class samples, false positive (FP):
the number of misclassified negative class members, and false
negative (FN): the number of misclassified positive class
samples. The standard performance evaluation metrics are
defined as follows:
Sensitivity =
TP
TP + FN
(8)
where sensitivity (or Recall) is the rate of correctly detected
positive samples in the positive class samples,
Specificity =
TN
TN + FP
(9)
where specificity is the ratio of accurately detected negative
class samples to all negative class samples,
Precision =
TP
TP + FP
(10)
where precision is the rate of correctly classified positive class
samples among all the members classified as positive samples,
Accuracy =
TP + TN
TP + TN + FP + FN
(11)
where accuracy is the ratio of correctly classified elements
among all the data,
F (β) = (1 + β2)
(Precision× Sensitivity)
β2 × Precision+ Sensitivity (12)
where F -score is defined by the weighting parameter β. The
F1-Score is calculated with β = 1, which is the harmonic
average of precision and sensitivity. The F2-score is calculated
with β = 2, which emphasizes FN minimization over FPs. The
main objective of both COVID-19 segmentation and detection
is to maximize sensitivity with a reasonable specificity in
order to minimize FP COVID-19 cases or pixels. Equivalently,
maximized F2-score is targeted with an acceptable F1-Score
value. The performances with their 95% confidence interval
(CI) for both COVID-19 infected region segmentation and
detection are given in Tables I and III, respectively. The range
of values can be calculated for each performance as follows:
r = ±z
√
metric(1−metric)/N, (13)
7TABLE I: Average performance metrics (%) for COVID-19 infected region segmentation computed on the test (unseen) set from
5 folds with three state-of-the-art segmentation models, four encoder architectures, and weight initializations. The initialized
encoder layers are set to frozen (3) and not frozen (7) states during the investigation.
Model Encoder EncoderLayers Sensitivity Specificity Precision F1-Score F2-Score Accuracy AUC
U-Net
CheXNet 3 81.20± 1.6× 10−4 99.55± 5× 10−6 83.78± 2.6× 10−5 82.47± 2.7× 10−5 81.70± 2.7× 10−5 99.03± 6.9× 10−6 99.19± 6.3× 10−6
CheXNet 7 82.23± 1.6× 10−4 99.56± 5× 10−6 84.54± 2.5× 10−5 83.34± 2.6× 10−5 82.66± 2.7× 10−5 99.08± 6.7× 10−6 99.18± 6.3× 10−6
DenseNet-121 3 82.29± 1.6× 10−4 99.61± 4× 10−6 86.02± 2.4× 10−5 84.11± 2.6× 10−5 83.01± 2.6× 10−5 99.13± 6.5× 10−6 99.35± 5.6× 10−6
DenseNet-121 7 84.00± 1.5× 10−4 99.66± 4× 10−6 87.77± 2.3× 10−5 85.81± 2.5× 10−5 84.71± 2.5× 10−5 99.22± 6.2× 10−6 99.19± 6.3× 10−6
Inception-v3 3 80.42± 1.7× 10−4 99.59± 5× 10−6 84.94± 2.5× 10−5 82.62± 2.7× 10−5 81.28± 2.7× 10−5 99.05± 6.8× 10−6 99.20± 6.3× 10−6
Inception-v3 7 82.34± 1.6× 10−4 99.70± 4× 10−6 88.87± 2.2× 10−5 85.43± 2.5× 10−5 83.54± 2.6× 10−5 99.21± 6.2× 10−6 98.82± 7.6× 10−6
ResNet-50 3 81.43± 1.6× 10−4 99.62± 4× 10−6 86.07± 2.4× 10−5 83.67± 2.6× 10−5 82.31± 2.6× 10−5 99.11± 6.6× 10−6 99.30± 5.9× 10−6
ResNet-50 7 79.90± 1.7× 10−4 99.70± 4× 10−6 88.64± 2.2× 10−5 83.89± 2.6× 10−5 81.43± 2.7× 10−5 99.15± 6.5× 10−6 98.98± 7.1× 10−6
UNet++
CheXNet 3 80.29± 1.7× 10−4 99.59± 5× 10−6 85.19± 2.5× 10−5 82.64± 2.7× 10−5 81.21± 2.7× 10−5 99.05± 6.8× 10−6 99.01± 7× 10−6
CheXNet 7 81.45± 1.6× 10−4 99.60± 5× 10−6 85.60± 2.5× 10−5 83.47± 2.6× 10−5 82.24± 2.7× 10−5 99.09± 6.7× 10−6 99.01± 7× 10−6
DenseNet-121 3 82.38± 1.6× 10−4 99.61± 4× 10−6 85.99± 2.4× 10−5 84.14± 2.6× 10−5 83.08± 2.6× 10−5 99.13± 6.5× 10−6 99.19± 6.3× 10−6
DenseNet-121 7 82.36± 1.6× 10−4 99.68± 4× 10−6 88.07± 2.3× 10−5 85.08± 2.5× 10−5 83.42± 2.6× 10−5 99.19± 6.3× 10−6 99.30± 5.9× 10−6
Inception-v3 3 82.87± 1.6× 10−4 99.57± 5× 10−6 84.83± 2.5× 10−5 83.81± 2.6× 10−5 83.24± 2.6× 10−5 99.10± 6.6× 10−6 99.21± 6.2× 10−6
Inception-v3 7 83.49± 1.6× 10−4 99.66± 4× 10−6 87.60± 2.3× 10−5 85.45± 2.5× 10−5 84.22± 2.6× 10−5 99.20± 6.3× 10−6 99.18± 6.3× 10−6
ResNet-50 3 82.07± 1.6× 10−4 99.59± 5× 10−6 85.41± 2.5× 10−5 83.71± 2.6× 10−5 82.72± 2.7× 10−5 99.10± 6.6× 10−6 99.15± 6.5× 10−6
ResNet-50 7 82.64± 1.6× 10−4 99.62± 4× 10−6 86.52± 2.4× 10−5 84.45± 2.5× 10−5 83.33± 2.6× 10−5 99.14± 6.5× 10−6 99.27± 6× 10−6
DLA
CheXNet 3 79.99± 1.7× 10−4 99.61± 4× 10−6 85.57± 2.5× 10−5 82.66± 2.7× 10−5 81.04± 2.8× 10−5 99.06± 6.8× 10−6 99.12± 6.6× 10−6
CheXNet 7 82.84± 1.6× 10−4 99.56± 5× 10−6 84.63± 2.5× 10−5 83.71± 2.6× 10−5 83.19± 2.6× 10−5 99.09± 6.7× 10−6 99.17± 6.4× 10−6
DenseNet-121 3 82.48± 1.6× 10−4 99.62± 4× 10−6 86.40± 2.4× 10−5 84.36± 2.6× 10−5 83.21± 2.6× 10−5 99.14± 6.5× 10−6 99.16± 6.4× 10−6
DenseNet-121 7 82.84± 1.6× 10−4 99.56± 5× 10−6 84.63± 2.5× 10−5 83.71± 2.6× 10−5 83.19± 2.6× 10−5 99.09± 6.7× 10−6 99.17± 6.4× 10−6
Inception-v3 3 80.28± 1.7× 10−4 99.63± 4× 10−6 86.43± 2.4× 10−5 83.19± 2.6× 10−5 81.41± 2.7× 10−5 99.09± 6.7× 10−6 99.02± 6.9× 10−6
Inception-v3 7 83.44± 1.6× 10−4 99.68± 4× 10−6 88.18± 2.3× 10−5 85.73± 2.5× 10−5 84.34± 2.6× 10−5 99.22± 6.2× 10−6 99.29± 5.9× 10−6
ResNet-50 3 81.26± 1.6× 10−4 99.63± 4× 10−6 86.48± 2.4× 10−5 83.78± 2.6× 10−5 82.25± 2.7× 10−5 99.12± 6.6× 10−6 99.08± 6.7× 10−6
ResNet-50 7 82.07± 1.6× 10−4 99.65± 4× 10−6 86.99± 2.4× 10−5 84.45± 2.5× 10−5 83.00± 2.6× 10−5 99.15± 6.5× 10−6 99.31± 5.8× 10−6
where z is the level of significance, metric is any perfor-
mance evaluation metric, and N is the number of samples.
Accordingly, z is set to 1.96 for 95% CI.
We have evaluated the networks in a stratified 5-fold cross-
validation scheme with a ratio of 80% training to 20% test
(unseen folds) over the benchmark QaTa-COVSeg dataset. The
input CXR images are resized to 224 × 224 pixels. Table II
shows the number of CXRs per class in the dataset. Since the
two classes are imbalanced, we have applied data augmen-
tation in order to balance the classes. Therefore, COVID-19
samples are augmented up to the same number of samples as
the normal class in the training set for each fold. The data
augmentation is performed using Image Data Generator in
Keras: the CXR samples are augmented by randomly shifting
them both vertically and horizontally by 10% and randomly
rotating them in a range of 10 degrees. After shifting and
rotating the images, blank sections are filled using the nearest
mode.
TABLE II: Number of CXR samples per-class and per-fold
before and after data augmentation.
Class Number ofSamples
Training
Samples
Augmented
Training Samples
Test
Samples
COVID-19 2951 2361 10035 590
Normal 12544 10035 10035 2509
Total 15495 12396 20070 3099
We have implemented the deep networks with Tensorflow
library [60] using Python on NVidia R© GeForce RTX 2080
Ti GPU card. For training, Adam optimizer [61] is used with
the default momentum parameters, β1 = 0.9 and β2 = 0.999
using the aforementioned hybrid loss function. The segmenta-
tion networks are trained with 50-epochs with a learning rate
of α = 10−4 and a batch size of 32.
For comparing the computed infection maps, the activation
maps are computed as follows: the encoder structures of the
segmentation networks are trained for the classification task
with a modification at the output layer by adding 2-neurons for
the number of total classes. The activation maps extracted from
the classification models are then compared with the infection
maps of the segmentation models. The classification networks,
CheXNet, DenseNet-121, Inception-v3 and ResNet-50 are
fine-tuned using categorical cross-entropy as loss function with
10 epochs and a learning rate of α = 10−5, which is a
sufficient setting to prevent over-fitting, based on our previous
study [29]. Other settings of the classifiers are kept the same
with the segmentation models.
B. Experimental Results
The experiments are carried out for both COVID-19 infected
region segmentation and COVID-19 detection. We extensively
tested the benchmark QaTa-COVSeg dataset using three differ-
ent state-of-the-art segmentation networks with four different
encoder options. We also investigated the effect of frozen
encoder weights on the performance.
1) COVID-19 Infected Region Segmentation: The perfor-
mance of the segmentation models for COVID-19 infected
region segmentation are presented in Table I. Each model
structure is evaluated with two configurations: frozen and not
frozen encoder layers. We have used transfer learning on
the encoder layers with ImageNet weights, except for the
CheXNet model, which is pre-trained on the ChestX-ray14
dataset. The evaluation of the models with frozen encoder
layers is also important since this process can lead to a better
convergence and improved performance. However, as the
results show, better performance is obtained when the network
continues to learn on the encoder layers as well. For each
model, we have observed that two encoders: DenseNet-121
and Inception-v3 are the top-performing ones for the infected
region segmentation task. The U-Net model with DenseNet-
121 encoder holds the leading performance by 84% sensi-
tivity, 85.81% F1-Score, and 84.71% F2-Score. DenseNet-
121 produces better results compared to other encoder types
since it can preserve the information coming from earlier
layers through the output by concatenating the feature maps
8TABLE III: Average COVID-19 detection performance results (%) computed from 5 folds over the test (unseen) set with three
network models, four encoder architectures, and weight initializations. The initialized encoder layers are set to frozen (3) and
not frozen (7) states during the investigation.
Encoder EncoderLayers Sensitivity Specificity Precision F1-Score F2-Score Accuracy
U
-N
et
CheXNet 3 97.56± 0.0056 91.10± 0.0050 72.07± 0.0071 82.90± 0.0059 91.11± 0.0045 92.33± 0.0042
CheXNet 7 97.97± 0.0051 92.74± 0.0045 76.04± 0.0067 85.62± 0.0055 92.62± 0.0041 93.73± 0.0038
DenseNet-121 3 98.07± 0.0050 94.66± 0.0039 81.20± 0.0062 88.84± 0.0050 94.16± 0.0037 95.31± 0.0033
DenseNet-121 7 98.37± 0.0046 98.05± 0.0024 92.25± 0.0042 95.21± 0.0034 97.08± 0.0027 98.12± 0.0021
Inception-v3 3 97.93± 0.0051 90.00± 0.0052 69.74± 0.0072 81.47± 0.0061 90.61± 0.0046 91.51± 0.0044
Inception-v3 7 97.22± 0.0059 98.37± 0.0022 93.33± 0.0039 95.24± 0.0034 96.42± 0.0029 98.15± 0.0021
ResNet-50 3 98.24± 0.0047 93.88± 0.0042 79.06± 0.0064 87.61± 0.0052 93.69± 0.0038 94.71± 0.0035
ResNet-50 7 96.37± 0.0067 97.82± 0.0026 91.21± 0.0045 93.72± 0.0038 95.30± 0.0033 97.54± 0.0024
U
N
et
++
CheXNet 3 97.80± 0.0053 91.70± 0.0048 73.49± 0.0069 83.92± 0.0058 91.73± 0.0043 92.86± 0.0041
CheXNet 7 97.49± 0.0056 93.65± 0.0043 78.33± 0.0065 86.87± 0.0053 92.94± 0.0040 94.39± 0.0036
DenseNet-121 3 97.70± 0.0054 94.81± 0.0039 81.58± 0.0061 88.91± 0.0049 93.98± 0.0037 95.36± 0.0033
DenseNet-121 7 96.51± 0.0066 99.16± 0.0016 96.44± 0.0029 96.48± 0.0029 96.50± 0.0029 98.66± 0.0018
Inception-v3 3 98.31± 0.0047 90.54± 0.0051 70.96± 0.0071 82.43± 0.0060 91.27± 0.0044 92.02± 0.0043
Inception-v3 7 96.92± 0.0061 98.37± 0.0022 93.34± 0.0039 95.10± 0.0034 96.18± 0.0030 98.10± 0.0021
ResNet-50 3 97.80± 0.0053 93.39± 0.0043 77.69± 0.0066 86.59± 0.0054 92.98± 0.0040 94.23± 0.0037
ResNet-50 7 96.78± 0.0064 97.43± 0.0028 89.87± 0.0048 93.20± 0.0040 95.31± 0.0033 97.31± 0.0025
D
L
A
CheXNet 3 97.46± 0.0057 92.47± 0.0046 75.27± 0.0068 84.94± 0.0056 92.03± 0.0043 93.42± 0.0039
CheXNet 7 97.32± 0.0058 94.93± 0.0038 81.87± 0.0061 88.93± 0.0049 93.78± 0.0038 95.39± 0.0033
DenseNet-121 3 97.36± 0.0058 95.66± 0.0036 84.08± 0.0058 90.23± 0.0047 94.38± 0.0036 95.99± 0.0031
DenseNet-121 7 97.09± 0.0061 99.07± 0.0017 96.08± 0.0031 96.58± 0.0029 96.88± 0.0027 98.69± 0.0018
Inception-v3 3 96.92± 0.0062 93.24± 0.0044 77.13± 0.0066 85.90± 0.0055 92.19± 0.0042 93.94± 0.0040
Inception-v3 7 96.71± 0.0064 99.13± 0.0016 96.32± 0.0030 96.52± 0.0029 96.63± 0.0028 98.67± 0.0018
ResNet-50 3 97.49± 0.0056 95.30± 0.0037 82.98± 0.0059 89.65± 0.0048 94.20± 0.0037 95.71± 0.0032
ResNet-50 7 96.17± 0.0069 98.15± 0.0024 92.44± 0.0042 94.27± 0.0037 95.40± 0.0033 97.77± 0.0023
from each dense layer. However, in the other segmentation
models, Inception-v3 outperforms the other encoder types. The
presented segmentation performances are obtained by setting
the threshold value to 0.5 to compute the segmentation mask
from the network probabilities. The Precision-Recall curves
are plotted in Fig. 6 by varying this threshold value.
2) COVID-19 Detection: The performances of the seg-
mentation models for COVID-19 detection are presented in
Table III. All the models are evaluated by stratified a 5-fold
cross-validation scheme, and the table shows the averaged
Fig. 6: The Precision-Recall curves of the three leading models
all with the not frozen encoder layers setting.
results of these folds. The most crucial metric here is the
sensitivity since missing any patient with COVID-19 is critical.
In fact, the results indicate the robustness of the model as
the proposed approach can achieve high sensitivity levels of
98.37% with a 97.08% F2-Score. Additionally, the proposed
approach achieves an elegant specificity of 99.16%, indicating
a significantly low false alarm rate.
TABLE IV: Cumulative confusion matrices of COVID-19
detection by the best performing U-Net and UNet++ models
with DenseNet-121 encoder.
(a) U-Net DenseNet-121
U-Net PredictedNormal COVID-19
Ground
Truth
Normal 12300 244
COVID-19 48 2903
(b) UNet++ DenseNet-121
UNet++ PredictedNormal COVID-19
Ground
Truth
Normal 12439 105
COVID-19 103 2848
It can be observed from Table III that DenseNet-121 encoder
with the not frozen encoder layer setting gives the most
promising results among the others. The confusion matrices,
accumulated on each fold’s test set, are presented in Table
IV. The highest sensitivity in COVID-19 detection is achieved
by the U-Net DenseNet-121 model (Table IVa). Accordingly,
the U-Net DenseNet-121 model only misses 48 COVID-19
patients out of 2951. On the other hand, the highest specificity
is achieved by UNet++ DenseNet-121 model (Table IVb). The
UNet++ model only misses a minor part of the normal class
9Fig. 7: Several CXR images with their corresponding ground-truth masks. The activation maps extracted from the classification
models are presented in the middle block. The last block is the generated infection maps from the segmentation models. It is
evident that the infection maps yield a superior localization of COVID-19 infection compared to activation maps.
with 105 samples out of 12544.
C. Infection vs Activation Maps
Several studies [31]–[33] propose to localize COVID-19
from CXRs by extracting activation maps from the deep
classification models trained for COVID-19 detection. Despite
the simplicity of the idea, there are many limitations of this ap-
proach. First of all, without any infected region segmentation
ground-truth masks, the network can only produce a rough
localization, and the extracted activation maps may entirely
fail to localize COVID-19 infection.
In this study, we check the reliability of our proposed
COVID-19 detection approach by comparing it with DL mod-
els trained for the classification task. In order to achieve this
objective, we compare the infection map and activation map
of CXR images, which are generated from the segmentation
and classification networks, respectively. Therefore, we have
trained the encoder structures of the segmentation networks,
which are CheXNet, DenseNet-121, Inception-v3, and ResNet-
50 to perform COVID-19 classification task in a stratified
5-fold cross-validation scheme. We have extracted activation
maps from these trained models by the Gradient-weighted
Class Activation Mapping (Grad-CAM) approach proposed in
[62]. The localization Grad-CAM LcGrad-CAM ∈ Rh×w of height
h and width w for class c is calculated by the gradient of mc
before the softmax with respect to the convolutional layer’s
feature maps Ak as ∂m
c
∂Ak
. The gradients are passed through
from the global average pooling during back-propagation;
αck =
1
Z
∑
i
∑
j
∂mc
∂Ak
, (14)
where α is the weight that shows the important feature map
k from A for a target class c. Then, the linear combination is
performed following by ReLU to obtain the Grad-CAM;
LcGrad-CAM = ReLU(
∑
k
αckA
k). (15)
Despite their elegant performance, activation maps extracted
from deep classification networks are not suitable for localiz-
ing COVID-19 infection as depicted in Fig 7. In fact, infections
found by the activation maps are highly irrelevant indicating
false locations outside of the lung areas. On the other hand,
infection maps can generate a highly accurate location with an
elegant severity grading of COVID-19 infection. The proposed
infection maps can conveniently be used by medical experts
for an enhanced assessment of the disease. Real-time imple-
mentation of the infection maps will obviously speed up the
detection process, cal also monitor the progression of COVID-
19 infection in the lungs.
D. Computational Complexity Analysis
In this section, we present the computational times of
the networks and their number of trainable & non-trainable
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parameters. Table V shows the elapsed time in milliseconds
(ms) during the inference step for each network used in the
experiments. The results in the table represent the running
time per sample. It can be observed from the table that the U-
Net model is the fastest among the others due to its shallow
structure. The fastest network is U-Net Inception-v3 with
frozen encoder layers taking up 2.53 ms. On the other hand,
the slowest model is UNet++ structure since it has the largest
number of trainable parameters. The most computationally
demanding model is UNet++ ResNet-50 with frozen encoder
layers, which takes 5.58 ms. We therefore conclude that all
models can be used as real-time clinical applications.
TABLE V: The number of trainable and non-trainable param-
eters of the models with their inference time (ms) per sample.
The initialized encoder layers are set to frozen (3) or not
frozen (7).
Encoder
Encoder
Layers
Frozen
Trainable Non-Trainable Time(ms)
U
-N
et
CheXNet 3 5.19M 6.96M 2.56
DensNet-121 3 5.19M 6.96M 2.58
Inception-v3 3 8.15M 21.79M 2.53
ResNet-50 3 9.06M 23.50M 2.54
CheXNet 3 12.06M 85.63K 2.62
DenseNet-121 7 12.06M 85.63K 2.58
Inception-v3 7 29.9M 36.42K 2.61
ResNet-50 7 32.51M 47.56K 2.64
U
N
et
++
CheXNet 3 7.53M 6.96M 5.17
DenseNet-121 3 7.53M 6.96M 5.10
Inception-v3 3 8.68M 21.79M 5.32
ResNet-50 3 10.88M 23.51M 5.58
CheXNet 7 14.40M 88.45K 5.24
DenseNet-121 7 14.40M 88.45K 5.25
Inception-v3 7 30.43M 39.23K 5.32
ResNet-50 7 34.34M 50.37K 5.46
D
L
A
CheXNet 3 6.27M 6.96M 4.65
DensNet-121 3 6.27M 6.96M 4.63
Inception-v3 3 7.20M 21.79M 4.70
ResNet-50 3 8.74M 23.51M 4.90
CheXNet 7 13.15M 88.45K 4.63
DenseNet-121 7 13.15M 88.45K 4.65
Inception-v3 7 28.96M 39.23K 4.72
ResNet-50 7 32.2M 50.37K 4.90
IV. CONCLUSIONS
The immediate and accurate detection of highly infectious
COVID-19 plays a vital role in preventing the spread of the
virus. In this study, we used CXR images since X-ray imaging
is cheaper, easily accessible, and faster than the conventional
methods commonly used such as RT-PCR and CT. As a major
contribution, the largest CXR dataset, QaTa-COVSeg, which
consists of 2951 COVID-19, and 12544 normal images, has
been compiled and will be shared publicly as a benchmark
dataset. Moreover, for the first time in the literature, we
release the ground-truth segmentation masks of the infected
regions along with the introduced benchmark QaTa-COVSeg.
Furthermore, we proposed a human-machine collaborative
approach, which can be used when fast and accurate ground-
truth annotation is desired but manual segmentation is slow,
costly, and subjective. Finally, we propose a joint approach
for the COVID-19 infection map generation and detection
by using state-of-the-art segmentation models. Our extensive
experiments on QaTa-COVSeg show that a reliable COVID-
19 diagnosis can be achieved by generating infection maps,
which can locate the infection on the lungs by 84% sensitivity,
and 85.81% F1-Score. Moreover, the proposed joint approach
can achieve an elegant COVID-19 detection performance with
98.37% sensitivity and 99.16% specificity. The most important
aspect of this study is that the generated infection maps can be
valuable from a medical perspective, whilst they can be used
for a better and objective COVID-19 assessment. It is clear
that when compared with the activation maps extracted from
deep models, infection maps are highly superior and reliable
mappings of COVID-19 infection.
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